41 results on '"Ariën, Kevin"'
Search Results
2. Diagnosing arthropod-borne flaviviruses: non-structural protein 1 (NS1) as a biomarker
3. Phylogeographic analysis of dengue virus serotype 1 and cosmopolitan serotype 2 in Africa
4. Arbovirus researchers unite: expanding genomic surveillance for an urgent global need
5. Head-to-head comparison of diagnostic accuracy of four Ebola virus disease rapid diagnostic tests versus GeneXpert® in eastern Democratic Republic of the Congo outbreaks: a prospective observational study
6. Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
7. Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
8. Characteristics of confirmed mpox cases among clinical suspects: A prospective single-centre study in Belgium during the 2022 outbreak
9. Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus
10. SARS-CoV-2 mRNA vaccination is not associated with the induction of anti-HLA or non-HLA antibodies
11. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
12. Field performance of three Ebola rapid diagnostic tests used during the 2018–20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study
13. Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients
14. Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
15. Seroprevalence and Seroreversion of SARS-CoV-2 Antibodies in a Cohort of Health Care Workers, Kinshasa, Democratic Republic of Congo
16. Asymptomatic Monkeypox Virus Infections Among Male Sexual Health Clinic Attendees in Belgium
17. Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2
18. Host Factors and Pathways Involved in the Entry of Mosquito-Borne Alphaviruses
19. Challenges in interpreting SARS-CoV-2 serological results in African countries
20. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay
21. Persistence of IgG response to SARS-CoV-2
22. Antibody Response after BNT162B2 COVID-19 mRNA Vaccination in Cancer Patients Under Anti-Neoplastic Treatment
23. A new genetic variant of dengue serotype 2 virus circulating in the Peruvian Amazon
24. Reliable Serological Diagnostic Tests for Arboviruses: Feasible or Utopia?
25. Two distinct lineages of chikungunya virus cocirculated in Aruba during the 2014–2015 epidemic
26. Japanese encephalitis in a young traveler returning from a short-term holiday in Khao Lak, Thailand
27. Dengue vaccine: reliably determining previous exposure
28. Can Zika virus antibodies cross-protect against dengue virus?
29. High mortality in non-Ebola virus disease cases: need to provide timely and effective care
30. Overlooking the importance of immunoassays – Authors' reply
31. Confirmed Zika virus infection in a Belgian traveler returning from Guatemala, and the diagnostic challenges of imported cases into Europe
32. Essentials of filoviral load quantification
33. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398
34. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds
35. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1
36. Synthesis, evaluation and structure–activity relationships of triazine dimers as novel antiviral agents
37. Novel diarylpyridinones, diarylpyridazinones and diarylphthalazinones as potential HIV-1 nonnucleoside reverse transcriptase inhibitors (NNRTIs)
38. Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity
39. A combined genotypic and phenotypic human immunodeficiency virus type 1 recombinant virus assay for the reverse transcriptase and integrase genes
40. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort
41. Replicative fitness of CCR5-using and CXCR4-using human immunodeficiency virus type 1 biological clones
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.